Literature DB >> 30468776

Interlaboratory variability in multiplexed pneumococcal antibody testing.

David C LaFon1, Moon H Nahm2.   

Abstract

Entities:  

Year:  2018        PMID: 30468776      PMCID: PMC6684100          DOI: 10.1016/j.jaci.2018.10.057

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  8 in total

Review 1.  Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides.

Authors:  Catherine M Wernette; Carl E Frasch; Dace Madore; George Carlone; David Goldblatt; Brian Plikaytis; William Benjamin; Sally A Quataert; Steve Hildreth; Daniel J Sikkema; Helena Käyhty; Ingileif Jonsdottir; Moon H Nahm
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

2.  Making sense of serotype-specific pneumococcal antibody measurements.

Authors:  Sarah C Beck
Journal:  Ann Clin Biochem       Date:  2013-09-17       Impact factor: 2.057

3.  Questioning the accuracy of currently available pneumococcal antibody testing.

Authors:  Joud Hajjar; Aba Al-Kaabi; Carleigh Kutac; James Dunn; William T Shearer; Jordan S Orange
Journal:  J Allergy Clin Immunol       Date:  2018-06-21       Impact factor: 10.793

4.  Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology.

Authors:  Jordan S Orange; Mark Ballow; E Richard Stiehm; Zuhair K Ballas; Javier Chinen; Maite De La Morena; Dinakantha Kumararatne; Terry O Harville; Paul Hesterberg; Majed Koleilat; Sean McGhee; Elena E Perez; Jason Raasch; Rebecca Scherzer; Harry Schroeder; Christine Seroogy; Aarnoud Huissoon; Ricardo U Sorensen; Rohit Katial
Journal:  J Allergy Clin Immunol       Date:  2012-09       Impact factor: 10.793

5.  Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations.

Authors:  R U Sorensen; L E Leiva; F C Javier; D M Sacerdote; N Bradford; B Butler; P A Giangrosso; C Moore
Journal:  J Allergy Clin Immunol       Date:  1998-08       Impact factor: 10.793

6.  Multilaboratory assessment of threshold versus fold-change algorithms for minimizing analytical variability in multiplexed pneumococcal IgG measurements.

Authors:  Thomas M Daly; Jerry W Pickering; Xiaochun Zhang; Harry E Prince; Harry R Hill
Journal:  Clin Vaccine Immunol       Date:  2014-05-07

7.  Impact of analytical variability on clinical interpretation of multiplex pneumococcal serology assays.

Authors:  Xiaochun Zhang; Kelly Simmerman; Belinda Yen-Lieberman; Thomas M Daly
Journal:  Clin Vaccine Immunol       Date:  2013-05-15

8.  Fifth Percentile Cutoff Values for Antipneumococcal Polysaccharide and Anti-Salmonella typhi Vi IgG Describe a Normal Polysaccharide Response.

Authors:  Heidi Schaballie; Barbara Bosch; Rik Schrijvers; Marijke Proesmans; Kris De Boeck; Mieke Nelly Boon; François Vermeulen; Natalie Lorent; Doreen Dillaerts; Glynis Frans; Leen Moens; Inge Derdelinckx; Willy Peetermans; Bjørn Kantsø; Charlotte Svaerke Jørgensen; Marie-Paule Emonds; Xavier Bossuyt; Isabelle Meyts
Journal:  Front Immunol       Date:  2017-05-12       Impact factor: 7.561

  8 in total
  2 in total

1.  Peripheral CD4 T follicular cells induced by a conjugated pneumococcal vaccine correlate with enhanced opsonophagocytic antibody responses in younger individuals.

Authors:  Sarah Sterrett; Binghao J Peng; Robert L Burton; David C LaFon; Andrew O Westfall; Suddham Singh; Michael Pride; Annaliesa S Anderson; Gregory C Ippolito; Harry W Schroeder; Moon H Nahm; A Krishna Prasad; Paul Goepfert; Anju Bansal
Journal:  Vaccine       Date:  2020-01-03       Impact factor: 3.641

2.  Diagnostic Vaccination in Clinical Practice.

Authors:  Anette Tarp Hansen; Anna Söderström; Charlotte Sværke Jørgensen; Carsten Schade Larsen; Mikkel Steen Petersen; Jens Magnus Bernth Jensen
Journal:  Front Immunol       Date:  2021-09-30       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.